Omada Health will release Q1 2026 results on May 7 and host a conference call at 4:30 PM ET.
Quiver AI Summary
Omada Health, a virtual healthcare provider focused on chronic conditions, announced that it will release its first quarter 2026 financial results on May 7, 2026, after the market closes, followed by a conference call at 4:30 PM ET to discuss the results. Investors can access a live audio webcast of the call and a replay at the provided link. Omada Health employs a virtual-first model combining human care teams, connected devices, and AI technology to support patients managing conditions like obesity, diabetes, and hypertension, serving over two million members since its launch across numerous healthcare partners.
Potential Positives
- Omada Health will be releasing its first quarter 2026 results, which provides an opportunity for investors to gain insights into the company’s financial performance and strategic direction.
- The company has served over two million members, indicating a strong customer base and potential for sustained revenue growth.
- Omada's innovative virtual-first healthcare model addresses chronic conditions effectively, highlighting its relevance and potential impact in the evolving healthcare landscape.
- The upcoming conference call and webcast will facilitate transparency and engagement with investors and stakeholders.
Potential Negatives
- The press release lacks specific financial data or performance metrics from the previous quarter, which could raise concerns among investors about transparency and the company's current financial health.
- The announcement of the results in the future could indicate a period of uncertainty leading up to the release, potentially affecting stock performance and investor confidence.
- While the focus on chronic conditions is significant, it may signal that traditional healthcare solutions are failing, which might reflect negatively on the industry's effectiveness overall and may affect the company's reputation as a leading provider.
FAQ
When will Omada Health release its Q1 2026 results?
Omada Health will release its first quarter 2026 results on Thursday, May 7, 2026, after market close.
What time will the conference call take place?
The conference call to review the results will take place at 4:30 pm ET on the same day.
How can I access the conference call?
A live audio webcast of the call will be available at https://investors.omadahealth.com.
Will there be a replay of the conference call?
Yes, a replay will be available shortly after the call and accessible for approximately 12 months.
What is Omada Health's mission?
Omada Health aims to transform healthcare delivery by focusing on support for chronic conditions outside of traditional doctor visits.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$OMDA Insider Trading Activity
$OMDA insiders have traded $OMDA stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $OMDA stock by insiders over the last 6 months:
- SEAN P. DUFFY (Chief Executive Officer) has made 0 purchases and 6 sales selling 284,604 shares for an estimated $4,446,580.
- WEI-LI SHAO (President) has made 0 purchases and 2 sales selling 8,447 shares for an estimated $126,591.
- STEVEN L. COOK (Chief Financial Officer) has made 0 purchases and 2 sales selling 6,095 shares for an estimated $90,967.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$OMDA Revenue
$OMDA had revenues of $75.8M in Q4 2025. This is an increase of 58.08% from the same period in the prior year.
You can track OMDA financials on Quiver Quantitative's OMDA stock page.
$OMDA Hedge Fund Activity
We have seen 99 institutional investors add shares of $OMDA stock to their portfolio, and 36 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- REVELATION CAPITAL MANAGEMENT, LLC added 5,208,034 shares (+inf%) to their portfolio in Q4 2025, for an estimated $82,182,776
- MILLENNIUM MANAGEMENT LLC added 2,096,705 shares (+1195.0%) to their portfolio in Q4 2025, for an estimated $33,086,004
- CITADEL ADVISORS LLC added 1,245,277 shares (+5330.1%) to their portfolio in Q4 2025, for an estimated $19,650,471
- A16Z CAPITAL MANAGEMENT, L.L.C. removed 1,153,645 shares (-25.0%) from their portfolio in Q4 2025, for an estimated $18,204,518
- JEFFERIES FINANCIAL GROUP INC. added 1,073,991 shares (+inf%) to their portfolio in Q4 2025, for an estimated $16,947,577
- DIVISADERO STREET CAPITAL MANAGEMENT, LP removed 910,344 shares (-66.0%) from their portfolio in Q4 2025, for an estimated $14,365,228
- MADRYN ASSET MANAGEMENT, LP added 583,800 shares (+inf%) to their portfolio in Q4 2025, for an estimated $9,212,364
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$OMDA Analyst Ratings
Wall Street analysts have issued reports on $OMDA in the last several months. We have seen 4 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Barclays issued a "Overweight" rating on 01/05/2026
- BMO Capital issued a "Outperform" rating on 11/13/2025
- Needham issued a "Buy" rating on 11/07/2025
- Evercore ISI Group issued a "Outperform" rating on 11/07/2025
To track analyst ratings and price targets for $OMDA, check out Quiver Quantitative's $OMDA forecast page.
$OMDA Price Targets
Multiple analysts have issued price targets for $OMDA recently. We have seen 10 analysts offer price targets for $OMDA in the last 6 months, with a median target of $20.0.
Here are some recent targets:
- Constantine Davides from Citizens set a target price of $18.0 on 04/14/2026
- David Roman from Goldman Sachs set a target price of $23.0 on 04/09/2026
- Elizabeth Anderson from Evercore ISI Group set a target price of $15.0 on 04/08/2026
- Destiny Jackson from JP Morgan set a target price of $26.0 on 03/12/2026
- Craig Hettenbach from Morgan Stanley set a target price of $30.0 on 03/06/2026
- Saket Kalia from Barclays set a target price of $18.0 on 03/06/2026
- Sean Dodge from BMO Capital set a target price of $18.0 on 03/06/2026
Full Release
SAN FRANCISCO, April 16, 2026 (GLOBE NEWSWIRE) -- Omada Health (Nasdaq: OMDA), the virtual between-visit healthcare provider, today announced that it will release its first quarter 2026 results on Thursday, May 7, 2026, after market close, and host a conference call to review the results at 4:30 pm ET the same day.
Conference Call Details
A live audio webcast of the call will be available online at https://investors.omadahealth.com . A replay will be available shortly after the conclusion of the call at the same link and will remain accessible for approximately 12 months.
Those participating via conference call can pre-register using the following link:
https://register-conf.media-server.com/register/BI854bc0e1054e4e9cabe5018d564013fe
About Omada Health
Omada Health (Nasdaq: OMDA) is reverse engineering the way healthcare is delivered in America, putting the space between doctor visits–where health is won or lost–at the center of care. Today's healthcare system poorly serves chronic conditions that require ongoing support outside of the exam room, like obesity, diabetes, hypertension, cholesterol, and musculoskeletal conditions. Omada’s virtual-first model combines human-led care teams, connected devices, and AI-enabled technology to deliver personalized care at scale, including support for GLP-1 therapy. Omada has served more than two million members since launch across 2,000+ employers, health plans, pharmacy benefit managers, and health systems. Learn more at omadahealth.com.
Contacts
Craig Gracey
[email protected]
Rose Ramseth
[email protected]
